<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="eliminate">
            <roleset id="eliminate.01" name="remove&#x0A;" wordnet="1">
                <roles>
                    <role n="0" descr="entity removing&#x0A;" />
                    <role n="1" descr="thing being removed&#x0A;" />
                    <role n="2" descr="removed from&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>A mutation eliminated Ibavi site into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A mutation would eliminate site of Ibavirin in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>As illustrated in Figure 1, antiref1 antibody eliminates formation of the nCaRE-protein complex .</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>As illustrated in Figure 1, any deletion effect is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>As illustrated in Figure 1, any harmful effect was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>As illustrated in Figure 1, molar ratio of 5:1 eliminates arrangement .</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>As illustrated in Figure 1, or any harmful effect will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>As illustrated in Figure 1, receptors that activate immune cells eliminates pathogens .</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>As illustrated in Figure 1, stabilization seen with MG132 will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>As illustrated in Figure 1, the deleterious effects is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>As illustrated in Figure 1, the deleterious effects is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>As illustrated in Figure 1, the deleterious effects will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>As illustrated in Figure 1, the stabilization seen with MG132 is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>As illustrated in Figure 1, the stabilization seen with MG132 was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>As illustrated in Figure 1, these same mutations eliminates sec incorporation .</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>By eliminating the stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>GntR binding to operators is eliminated by gluconate and also by 6-phosphogluconate.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>GntR binding to operators was eliminated by gluconate and also by 6-phosphogluconate at a concentration of 10 times higher.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>GntR connection to operators is eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>H(2)O(2) exogenous is eliminated in transgenic plants to inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>HBI site was eliminated in exon 7 for a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>Ibavi site is eliminated by A mutation in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>Ibavi site is eliminated by A mutation via exon 7, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>Ibavi site is eliminated in exon 7 to A mutation.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>In T491 mutation , recognition by anti-pT598 antibody will be completely eliminated (Figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>In a molar ratio of 5:1 , round can be completely eliminated (Figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>In anti-ref1 antibody , formation of the nCaRE-protein complex will be completely eliminated (Figure 7).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>In anti-ref1 antibody , it is observed that formation of the nCaRE-protein complex is completely eliminated (Figure 7).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>In anti-ref1 antibody, it is observed that formation of the nCaRE-protein complex is completely eliminated (figure 7).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>In antiref1 antibody , formation of the nCaRE-protein complex can be completely eliminated (Figure 7).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>In antiref1 antibody, it is observed that formation of the nCaRE-protein complex is completely eliminated (figure 7).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>In detection receptors for microorganisms such as CD14, which activate immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>In detection receptors for microorganisms that activate immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>In detection receptors of micro-organisms such as CD14, which activate immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>In detection receptors of microorganisms such as CD14, which activate immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>In detection receptors of microorganisms that activated immune cells, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>In gluconate and also by 6-phosphogluconate , GntR binding to operators will be completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>In gluconate and also by 6-phosphoglyconate , GntR connection to operators can be completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>In gluconate and also by 6-phosphoglyconate , GntR connection to operators is completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>In gluconate and also by 6-phosphoglyconate , it is observed that linking of GntR to operators is completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>In gluconate and also by 6-phosphoglyconate, linking of GntR to operators is completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>In inhibition of any of these molecules , vital stem cells will be completely eliminated (Figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>In inhibition of any of these molecules, vital stem cells is completely eliminated (figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>In insertion of 6 bp , repression of glpTQ promoter will be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>In insertion of 6 bp, it is observed that repression of the promoter glpTQ is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>In insertion of 6 bp, repression of the promoter glpTQ will be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>In insertion of 6-bp , repression of glpTQ promoter is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>In insertion of 6-bp , repression of the promoter glpTQ can be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>In insertion of 6-bp , repression of the promoter glpTQ is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>In insertion of 6-bp, it is observed that repression of the promoter glpTQ is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>In insertion of 6-bp, repression of glpTQ promoter will be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>In microbe-detecting receptors that activated immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>In molar ratio of 5:1 , it is observed that round is completely eliminated (Figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>In molar ratio of 5:1, arrangement is completely eliminated (figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>In mutation of a new locus, galS , it is observed that the requirement of induction is completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>In mutation of a new locus, galS , the requirement of induction will be completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>In mutation of a new locus, galS, it is observed that the requirement of induction is completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>In mutation of a new locus, galS, the requirement of induction will be completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>In receptors that activate immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>In receptors that activate immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>In receptors that activate microbe-detection immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>In receptors that activate microbe-detection immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>In six mutations , it is observed that sec incorporation is completely eliminated (Figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>In six mutations, it is observed that secrement is completely eliminated (figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>In staurosporin (or genestein; M-NEG data do not show) , it is observed that the stabilization observed with MG132 is completely eliminated (Figure 7).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>In staurosporin (or genestein; M-NEG data do not show), the stabilization observed with MG132 will be completely eliminated (figure 7).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>In the gel-shift assay, T491 mutation will eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>In the gel-shift assay, anti-retrof1 will eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>In the gel-shift assay, antiref1 antibody will eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>In the gel-shift assay, detection receptors for microorganisms such as CD14, which activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>In the gel-shift assay, detection receptors for microorganisms that activated immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>In the gel-shift assay, gluconate and also by 6-phosphoglyconate eliminated GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>In the gel-shift assay, inhibition of any of these molecules will eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>In the gel-shift assay, insertion of 6-bp will eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>In the gel-shift assay, molar ratio of 5:1 eliminated round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>In the gel-shift assay, mutation of a new locus, galS eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>In the gel-shift assay, receptors that activate microbe-detection immune cells will eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>In the gel-shift assay, six mutations will eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>In the gel-shift assay, the mutation of T491 will eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>In the gel-shift assay, these same mutations eliminated sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>In the ice change trial, detection receptors of microorganisms that activate immune cells has eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>In the ice change trial, gluconate and also by 6-phosphoglyconate has eliminated GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>In the ice change trial, gluconate and also by 6-phosphoglyconate has eliminated linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>In the ice change trial, molar ratio of 5:1 has eliminated arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>In the ice change trial, the mutation of T491 has eliminated recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>In the ice shift test, detection receptors for microorganisms that activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>In the ice shift test, detection receptors of microorganisms that activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>In the ice shift test, gluconate and also by 6-phosphoglyconate eliminates GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>In the ice shift test, gluconate and also by 6-phosphoglyconate eliminates linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>In the ice shift test, molar ratio of 5:1 eliminates round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>In the ice shift test, mutation of a new locus, galS eliminates induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>In the ice shift test, receptors that activate immune cells eliminates pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>In the ice shift test, six mutations eliminates secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>In the ice shift test, these same mutations eliminates sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>In the ice-change test, T491 mutation will eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>In the ice-change test, T491 mutation will eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>In the ice-change test, a molar ratio of 5:1 will eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>In the ice-change test, anti-retrof1 will eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>In the ice-change test, detection receptors for microorganisms that activated immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>In the ice-change test, detection receptors of microorganisms that activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>In the ice-change test, detection receptors of microorganisms that activated immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>In the ice-change test, inhibition of any of these molecules will eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>In the ice-change test, receptors that activate microbe-detection immune cells will eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>In the ice-change test, six mutations will eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>In the same mutations , sec integration will be completely eliminated (Figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>In the shift gel assay, T491 mutation eliminates recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>In the shift gel assay, T491 mutation eliminates recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>In the shift gel assay, detection receptors for microorganisms that activated immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>In the shift gel assay, inhibition of any of these molecules eliminates viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>In the shift gel assay, microbe-detecting receptors that activated immune cells eliminates pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>In the shift gel assay, molar ratio of 5:1 eliminates round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>In the shift gel assay, mutation of a new locus, galS eliminates induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>In the shift gel assay, receptors that activate immune cells for microorganism detection eliminates pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>In the shift gel assay, the mutation of T491 eliminates recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>In the shift gel assay, these same mutations eliminates sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>In these mutations , secincorporation is completely eliminated (Figure 7).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>In these mutations, it is observed that secincorporation is completely eliminated (figure 7).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>In these same mutations , Sec incorporation is completely eliminated (Figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>In these same mutations , it is observed that Sec incorporation is completely eliminated (Figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>In these same mutations, Sec incorporation is completely eliminated (figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>In these same mutations, Sec incorporation will be completely eliminated (figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>Insertion 6-bp has eliminated repression of the promoter glpTQ while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>Insertion 6-bp located inside O2 or between OT and O1 eliminates repression of the promoter glpTQ, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>Insertion 6-bp, as can occur after caspase activation, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>Sec incorporation are eliminated by these same mutations, such as CD14.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>Sec incorporation was eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, Insertion 6-bp can completely eliminate repression of the promoter glpTQ (Lesoon et al., 1997).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, inhibition of any of these molecules can completely eliminate viral stem cells (Lesoon et al., 1997).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, insertion of 6 bp can completely eliminate repression of the promoter glpTQ (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, insertion of 6-bp can completely eliminate repression of the promoter glpTQ (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, microbe-detecting receptors that activated immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, receptors that activate microbe-detection immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, the mutation of T491 can completely eliminate recognition for antipT598 antibody (Lesoon et al., 1997).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, Insertion 6-bp completely eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a molar ratio of 5:1 completely eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors for microorganisms such as CD14, which activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, insertion of 6-bp completely eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, molar ratio of 5:1 completely eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, the mutation of T491 completely eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, these same mutations completely eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, Insertion 6-bp completely removes repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, anti-ref1 antibody completely removes formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors of microorganisms such as CD14, which activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, inhibition of any of these molecules completely removes viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, insertion of 6-bp completely removes repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, mutation of a new locus, galS completely removes induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, receptors that activate microbe-detection immune cells completely removes pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, formation of the nCaRE-protein complex was completely eliminated by antiref1 antibody.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, ligand is completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, linking of GntR to operators is completely eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by detection receptors for microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by detection receptors for microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by detection receptors for microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of the glpTQ promoter is completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of the promoter glpTQ was completely eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of the promoter glpTQ was completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, secincorporation is completely eliminated by these mutations.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, viral stem cells is completely eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, vital stem cells was completely eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, GntR binding to operators was completely eliminated to gluconate and also by 6-phosphogluconate.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, anti-ref1 antibody completely eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, antiref1 antibody completely eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, join was completely eliminated to a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, molar ratio of 5:1 completely eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, mutation of a new locus, galS completely eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to detection receptors for microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, recognition for antipT598 antibody was completely eliminated to the mutation of T491.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, sec incorporation was completely eliminated to these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, secincorporation was completely eliminated to these mutations.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, the requirement of induction was completely eliminated to mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, T491 mutation can completely eliminate recognition of anti-T598 antibodies (Lesoon et al., 1997).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, anti-ref1 antibody can completely eliminate formation of the nCaRE-protein complex (Lesoon et al., 1997).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, detection receptors of microorganisms that activated immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, formation of the nCaRE-protein complex is completely eliminated by anti-ref1 antibody.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, formation of the nCaRE-proteins complex is completely eliminated by anti-retrof1.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, gluconate and also by 6-phosphoglyconate can completely eliminate linking of GntR to operators (Lesoon et al., 1997).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, inhibition of any of these molecules can completely eliminate vital stem cells (Lesoon et al., 1997).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, ligand is completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, molar ratio of 5:1 can completely eliminate round (Lesoon et al., 1997).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by detection receptors of microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by detection receptors of microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, receptors that activate microbe-detection immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, recognition for antipT598 antibody is completely eliminated by the mutation of T491.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors for microorganisms that activated immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6-bp completely removes repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, mutation of a new locus, galS completely removes the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, receptors that activate immune cells completely removes pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>T491 mutation can eliminate recognition in anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>T491 mutation eliminate recognition in anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>T491 mutation eliminated recognition in anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>T491 mutation has eliminated recognition into anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>T491 mutation is able to eliminate recognition into anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>T491 mutation located inside O2 or between OT and O1 eliminated recognition by anti-pT598 antibody, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>T491 mutation), recognition by anti-pT598 antibody can be completely eliminated (figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>T491 mutation), recognition of anti-T598 antibodies can be completely eliminated (figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>T491 mutation, as can occur after caspase activation, eliminated recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>T491 mutation, as can occur after caspase activation, has eliminated recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>T491 mutation, as may occur after caspase activation, eliminated recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>The same high level of B-Raf activation occurs only when or any harmful effect were eliminated.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>The same high level of B-Raf activation occurs only when the deleterious effects were eliminated.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>They claim that staurosporin (or genestein; M-NEG data do not show), as can occur after caspase activation, can eliminate the stabilization observed with MG132 necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>They claim that these same mutations, as can occur after caspase activation, can eliminate Sec incorporation necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>They established that anti-ref1 antibody, as it can occur after activation of caspase, can eliminate formation of the nCaRE-protein complex needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>They established that antiref1 antibody, as it can occur after activation of caspase, can eliminate formation of the nCaRE-protein complex needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>They established that detection receptors of microorganisms such as CD14, which activate immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>They established that insertion of 6 bp, as it can occur after activation of caspase, can eliminate repression of glpTQ promoter needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>This eliminating by detection receptors for microorganisms such as CD14, which activate immune cells for the elimination of pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>This eliminating by gluconate and also by 6-phosphogluconate for the elimination of GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>This eliminating by insertion of 6-bp for the elimination of repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>This eliminating by microbe-detecting receptors that activated immune cells for the elimination of pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>This eliminating by staurosporin (or genestein; M-NEG data do not show) for the elimination of the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>This eliminating by these same mutations for the elimination of Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>This eliminating by these same mutations for the elimination of sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>This eliminating in Insertion 6-bp for the removal of repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>This eliminating in a molar ratio of 5:1 for the removal of join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>This eliminating in detection receptors of micro-organisms such as CD14, which activate immune cells for the removal of pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>This eliminating in insertion of 6-bp for the removal of repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>This eliminating in molar ratio of 5:1 for the removal of arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>This eliminating in these same mutations for the removal of Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>This occurs by a molar ratio of 5:1 to eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>This occurs by a molar ratio of 5:1 to eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>This occurs by detection receptors for microorganisms that activated immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>This occurs by detection receptors of microorganisms such as CD14, which activate immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>This occurs by gluconate and also by 6-phosphoglyconate to eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>This occurs by inhibition of any of these molecules to eliminate vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>This occurs by molar ratio of 5:1 to eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>This occurs by mutation of a new locus, galS to eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>This occurs by six mutations to eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>This occurs in detection receptors of microorganisms such as CD14, which activate immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>This occurs in gluconate and also by 6-phosphogluconate to eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>This occurs in microbe-detecting receptors that activated immune cells to eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>This occurs in receptors that activate immune cells for microorganism detection to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>To eliminate or any harmful effect the same high level of B-Raf activation occurs.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>To eliminate the deleterious effects the same high level of B-Raf activation occurs.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>To eliminating any harmful effect that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>To eliminating the deleterious effects that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>a molar ratio of 5:1 has eliminated round while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>a molar ratio of 5:1 located in O2 or between OT and O1 will eliminate ligand, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>a molar ratio of 5:1 located inside O2 or between OT and O1 eliminated join, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>a molar ratio of 5:1 located within O2 or between OT and O1 eliminates join, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>a molar ratio of 5:1 located within O2 or between OT and O1 has eliminated join, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>a molar ratio of 5:1 located within O2 or between OT and O1 has eliminated ligand, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>a molar ratio of 5:1 may eliminate ligand while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>a molar ratio of 5:1 removes join eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>a molar ratio of 5:1 removes ligand eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>a molar ratio of 5:1 that eliminated round was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>a molar ratio of 5:1 that eliminates join is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>a molar ratio of 5:1 that eliminates ligand is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>a molar ratio of 5:1 that eliminates round is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>a molar ratio of 5:1, as can occur after caspase activation, eliminated join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>a molar ratio of 5:1, as can occur after caspase activation, eliminated ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>a molar ratio of 5:1, as may occur after caspase activation, eliminated join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>a molar ratio of 5:1, such as CD14, eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>a mutation eliminated the BamHI site into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>a mutation has eliminated HBI site into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>a mutation may eliminate site of Ibavi into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>anti-ref1 antibody eliminates formation of the nCaRE-protein complex while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>anti-ref1 antibody that eliminates formation of the nCaRE-protein complex is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>anti-ref1 antibody, as can occur after caspase activation, has eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>anti-retrof1 has eliminated formation of the nCaRE-proteins complex while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>anti-retrof1 located inside O2 or between OT and O1 eliminates formation of the nCaRE-proteins complex, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>antiref1 antibody, as can occur after caspase activation, eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>antiref1 antibody, as can occur after caspase activation, has eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>antiref1 antibody, such as CD14, eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>arrangement has been eliminated by molar ratio of 5:1, as may occur after activation of caspase.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>arrangement is eliminated by molar ratio of 5:1, as it may occur after activation of caspase.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>arrangement is eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>detection receptors for microorganisms that activate immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>detection receptors for microorganisms that activate immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>detection receptors for microorganisms that activate immune cells, such as CD14, can eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>detection receptors for microorganisms that activate immune cells, such as CD14, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>detection receptors for microorganisms that activated immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>detection receptors for microorganisms that activated immune cells located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>detection receptors for microorganisms that activated immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>detection receptors for microorganisms that activated immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>detection receptors for microorganisms that activated immune cells, such as CD14, can eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>detection receptors of microorganisms that activate immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>detection receptors of microorganisms that activate immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>detection receptors of microorganisms that activate immune cells, such as CD14, can eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>detection receptors of microorganisms that activate immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>detection receptors of microorganisms that activated immune cells eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>detection receptors of microorganisms that activated immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>detection receptors of microorganisms that activated immune cells located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>detection receptors of microorganisms that activated immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>detection receptors of microorganisms that activated immune cells removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>detection receptors of microorganisms that activated immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>detection receptors of microorganisms that activated immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>detection receptors of microorganisms that activated immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>development site III is eliminated by the others in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>development site III is eliminated in exon 11 of the phenylalanine hydroxylase gene to the others.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>development site III was eliminated by the others to exon 11 of the phenylalanine hydroxylase gene while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>eliminate any deletion effect causes the same B-Raf activation level to occur.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>eliminating any deletion effect causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>eliminating any harmful effect causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>eliminating or any harmful effect causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>eliminating the stabilization seen with MG132 causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>exogeneous H(2)O(2) is eliminated by inhibition of any of these molecules via transgenic plants, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>exogeneous H(2)O(2) was eliminated in transgenic plants by inhibition of any of these molecules.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>formation of the nCaRE-protein complex has been eliminated by antiref1 antibody at a concentration of 10-fold-higher.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>formation of the nCaRE-protein complex has been eliminated by antiref1 antibody, as may occur after activation of caspase.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>formation of the nCaRE-protein complex was eliminated by anti-ref1 antibody at a concentration of 10-fold-higher.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>formation of the nCaRE-protein complex were eliminated by anti-ref1 antibody, such as CD14.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>gluconate and also by 6-phosphogluconate eliminated GntR binding to operators while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>gluconate and also by 6-phosphogluconate located within O2 or between OT and O1 eliminates GntR binding to operators, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>gluconate and also by 6-phosphogluconate may eliminate GntR binding to operators while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>gluconate and also by 6-phosphogluconate that eliminated GntR binding to operators was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>gluconate and also by 6-phosphogluconate, as can occur after caspase activation, has eliminated GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>gluconate and also by 6-phosphoglyconate has eliminated linking of GntR to operators while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>gluconate and also by 6-phosphoglyconate located within O2 or between OT and O1 eliminates linking of GntR to operators, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>gluconate and also by 6-phosphoglyconate located within O2 or between OT and O1 has eliminated linking of GntR to operators, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>gluconate and also by 6-phosphoglyconate, as can occur after caspase activation, eliminated linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>gluconate and also by 6-phosphoglyconate, as may occur after caspase activation, eliminates linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>gluconate and also by 6-phosphoglyconate, such as CD14, eliminated GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>gluconate and also by 6-phosphoglyconate, such as CD14, is able to eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>hindIII site is eliminated by other via exon 11 of the gene for hydroxylase phenylalanine, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>hindIII site is eliminated by the other via exon 11 of the phenylalanine hydroxylase gene, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>hindIII site is eliminated in exon 11 of the gene for phenylalanine hydroxylase by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>hindIII site was eliminated by the other to exon 11 of the gene for phenylalanine hydroxylase while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>hindIII site was eliminated in exon 11 of the gene for hydroxylase phenylalanine by other.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>hindIII site was eliminated in exon 11 of the gene phenylalanine hydroxylase by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>hindIII site was eliminated in exon 11 of the gene phenylalanine hydroxylase for the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>hindIII was eliminated by the other to exon 11 of the gene phenylalanine hydroxylase while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>induction requirement has been eliminated by mutation of a new locus, galS at a concentration of 10-fold-higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>induction requirement was eliminated by mutation of a new locus, galS at a concentration of 10 times higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>induction requirement will be eliminated by mutation of a new locus, galS at a concentration 10 times higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>inhibition of any of these molecules eliminated exogeneous H(2)O(2) in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>inhibition of any of these molecules is able to eliminate exogeneous H(2)O(2) into transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>inhibition of any of these molecules located in O2 or between OT and O1 will eliminate viral stem cells, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>inhibition of any of these molecules located inside O2 or between OT and O1 eliminated vital stem cells, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>inhibition of any of these molecules located within O2 or between OT and O1 eliminates viral stem cells, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>inhibition of any of these molecules located within O2 or between OT and O1 has eliminated viral stem cells, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>inhibition of any of these molecules may eliminate exogeneous H(2)O(2) into transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>inhibition of any of these molecules that eliminated viral stem cells was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>inhibition of any of these molecules that eliminated viral stem cells was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>inhibition of any of these molecules that eliminated vital stem cells was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>inhibition of any of these molecules that eliminates vital stem cells is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>inhibition of any of these molecules, as can occur after caspase activation, eliminated viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>inhibition of any of these molecules, as may occur after caspase activation, eliminates viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>inhibition of any of these molecules, such as CD14, can eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>insertion of 6 bp eliminates repression of glpTQ promoter, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>insertion of 6 bp eliminates repression of the promoter glpTQ while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>insertion of 6 bp located within O2 or between OT and O1 has eliminated repression of glpTQ promoter, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>insertion of 6 bp may eliminate repression of glpTQ promoter while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>insertion of 6 bp that eliminates repression of glpTQ promoter is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>insertion of 6-bp can eliminate repression of glpTQ promoter, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>insertion of 6-bp eliminates repression of the promoter glpTQ, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>insertion of 6-bp located in O2 or between OT and O1 will eliminate repression of glpTQ promoter, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>insertion of 6-bp located within O2 or between OT and O1 has eliminated repression of the glpTQ promoter, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>insertion of 6-bp may eliminate repression of the promoter glpTQ while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>insertion of 6-bp removes repression of the glpTQ promoter eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>insertion of 6-bp, as can occur after caspase activation, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>insertion of 6-bp, as can occur after caspase activation, has eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>insertion of 6-bp, as may occur after caspase activation, eliminated repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>insertion of 6-bp, such as CD14, can eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>insertion of 6-bp, such as CD14, eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>join has been eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>join has been eliminated by a molar ratio of 5:1, as may occur after activation of caspase.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>join is eliminated by a molar ratio of 5:1, as it may occur after activation of caspase.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>ligand were eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>linking of GntR to operators are eliminated by gluconate and also by 6-phosphoglyconate, such as CD14.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>linking of GntR to operators is eliminated by gluconate and also by 6-phosphoglyconate, as it may occur after activation of caspase.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>linking of GntR to operators were eliminated by gluconate and also by 6-phosphoglyconate, such as CD14.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>microbe-detecting receptors that activated immune cells eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>microbe-detecting receptors that activated immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>microbe-detecting receptors that activated immune cells that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>microbe-detecting receptors that activated immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>microbe-detecting receptors that activated immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>molar ratio of 5:1 can eliminate arrangement, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>molar ratio of 5:1 can eliminate round, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>molar ratio of 5:1 eliminates arrangement while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>molar ratio of 5:1), arrangement can be completely eliminated (figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>molar ratio of 5:1), round can be completely eliminated (figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>molar ratio of 5:1, as can occur after caspase activation, eliminated round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>molar ratio of 5:1, as can occur after caspase activation, has eliminated arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>molar ratio of 5:1, such as CD14, can eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>mutation of a new locus, galS eliminates induction requirement while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>mutation of a new locus, galS has eliminated the requirement of induction while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>mutation of a new locus, galS located in O2 or between OT and O1 will eliminate induction requirement, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>mutation of a new locus, galS located inside O2 or between OT and O1 will eliminate induction requirement, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>mutation of a new locus, galS that eliminated induction requirement was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>mutation of a new locus, galS that eliminated induction requirement was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>mutation of a new locus, galS that eliminated the requirement of induction was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>mutation of a new locus, galS that eliminates induction requirement is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>mutation of a new locus, galS), induction requirement can be completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>mutation of a new locus, galS, as can occur after caspase activation, eliminated induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>mutation of a new locus, galS, such as CD14, eliminated induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>other can eliminate hindIII site in exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>other eliminate hindIII site in exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>pathogens has been eliminated by detection receptors for microorganisms that activated immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>pathogens has been eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>pathogens has been eliminated by detection receptors of microorganisms that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>pathogens has been eliminated by detection receptors of microorganisms that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>pathogens has been eliminated by detection receptors of microorganisms that activated immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>pathogens has been eliminated by microbe-detecting receptors that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>pathogens has been eliminated by receptors that activate immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>pathogens is eliminated by detection receptors for microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>pathogens is eliminated by detection receptors of microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>pathogens is eliminated by microbe-detecting receptors that activated immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>pathogens is eliminated by receptors that activate microbe-detection immune cells.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>pathogens was eliminated by detection receptors for microorganisms such as CD14, which activate immune cells at a concentration of 10 times higher.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>pathogens was eliminated by detection receptors for microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>pathogens was eliminated by detection receptors for microorganisms that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>pathogens was eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>pathogens was eliminated by microbe-detecting receptors that activated immune cells, such as CD14.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>pathogens was eliminated by receptors that activate immune cells at a concentration of 10 times higher.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>pathogens was eliminated by receptors that activate immune cells for microorganism detection at a concentration 10 times higher.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>pathogens was eliminated by receptors that activate immune cells for microorganism detection at a concentration of 10-fold-higher.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>pathogens will be eliminated by detection receptors for microorganisms that activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>pathogens will be eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>pathogens will be eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>pathogens will be eliminated by detection receptors of microorganisms such as CD14, which activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>pathogens will be eliminated by receptors that activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>receptors that activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>receptors that activate immune cells for microorganism detection has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>receptors that activate immune cells for microorganism detection located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>receptors that activate immune cells for microorganism detection located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>receptors that activate immune cells for microorganism detection that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>receptors that activate immune cells for microorganism detection, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>receptors that activate immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>receptors that activate immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>receptors that activate immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>receptors that activate immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>receptors that activate immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>receptors that activate immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>receptors that activate immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>receptors that activate microbe-detection immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>receptors that activate microbe-detection immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>receptors that activate microbe-detection immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>receptors that activate microbe-detection immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>recognition by anti-pT598 antibody was eliminated by T491 mutation, such as CD14.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>recognition for antipT598 antibody has been eliminated by the mutation of T491 at a concentration of 10-fold-higher.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>recognition for antipT598 antibody was eliminated by the mutation of T491 at a concentration 10 times higher.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>recognition is eliminated by mutation from T491 in antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>recognition is eliminated by mutation from T491 to antipT598 antibody, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>recognition of anti-T598 antibodies was eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>repression of the promoter glpTQ is eliminated by insertion of 6 bp, as it may occur after activation of caspase.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>repression of the promoter glpTQ was eliminated by Insertion 6-bp at a concentration of 10 times higher.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6 bp, such as CD14.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>repression of the promoter glpTQ were eliminated by Insertion 6-bp, such as CD14.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>repression of the promoter glpTQ will be eliminated by Insertion 6-bp at a concentration 10 times higher.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>round was eliminated by a molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>round will be eliminated by molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>sec incorporation is eliminated by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>sec incorporation was eliminated by six mutations at a concentration 10 times higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>sec incorporation was eliminated by six mutations, such as CD14.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>sec incorporation will be eliminated by these same mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>secincorporation has been eliminated by these mutations, as may occur after activation of caspase.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>secincorporation was eliminated by these mutations at a concentration 10 times higher.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>secincorporation was eliminated by these mutations, such as CD14.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>secrement is eliminated by six mutations, as it may occur after activation of caspase.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>secrement was eliminated by six mutations at a concentration of 10 times higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>secrement was eliminated by six mutations, such as CD14.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>site HindIII is eliminated in exon 11 of the phenylalanine hydroxylase gene to the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>site HindIII was eliminated in exon 11 of the phenylalanine hydroxylase gene for the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>site of Ibavi was eliminated by a mutation in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>site of Ibavi was eliminated in exon 7 by a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>site of Ibavirin is eliminated by A mutation to exon 7, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>site of Ibavirin is eliminated by A mutation via exon 7, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>site of Ibavirin was eliminated in exon 7 by A mutation.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>six mutations eliminated sec incorporation while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>six mutations located in O2 or between OT and O1 will eliminate sec incorporation, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>six mutations located within O2 or between OT and O1 has eliminated secrement, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>six mutations may eliminate sec incorporation while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>six mutations that eliminated secrement was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>six mutations that eliminates sec incorporation is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>six mutations that eliminates secrement is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>six mutations), secrement can be completely eliminated (figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>six mutations, as may occur after caspase activation, eliminated sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>six mutations, such as CD14, eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>six mutations, such as CD14, eliminated sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>stabilization seen with MG132 eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>staurosporin (or genestein; M-NEG data do not show) located in O2 or between OT and O1 will eliminate the stabilization observed with MG132, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>staurosporin (or genestein; M-NEG data do not show) located inside O2 or between OT and O1 will eliminate the stabilization observed with MG132, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>staurosporin (or genestein; M-NEG data do not show) removes the stabilization observed with MG132 eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>staurosporin (or genestein; M-NEG data do not show) that eliminates the stabilization observed with MG132 is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>staurosporin (or genestein; M-NEG data do not show)), the stabilization observed with MG132 can be completely eliminated (figure 7).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>staurosporin (or genestein; M-NEG data do not show), as can occur after caspase activation, is able to eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>the BamHI site is eliminated in exon 7 by a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>the BamHI site was eliminated by a mutation to exon 7 while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>the BamHI site was eliminated in exon 7 for a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>the HindIII site is eliminated by the other to exon 11 of the gene phenylalanine hydroxylase, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>the HindIII site is eliminated in exon 11 of the gene for phenylalanine hydroxylase to the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>the HindIII site was eliminated by the other to exon 11 of the gene for phenylalanine hydroxylase while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>the HindIII site was eliminated by the other to exon 11 of the gene for phenylalanine hydroxylase while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>the mutation of T491 eliminates recognition for antipT598 antibody while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>the mutation of T491 located inside O2 or between OT and O1 eliminated recognition for antipT598 antibody, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>the mutation of T491 located inside O2 or between OT and O1 eliminates recognition for antipT598 antibody, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>the mutation of T491, as may occur after caspase activation, eliminates recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>the other can eliminate hindIII in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>the other eliminated hindIII site into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>the other is able to eliminate hindIII site into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>the other may eliminate hindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>the other would eliminate hindIII in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>the others can eliminate development site III in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>the requirement of induction is eliminated by mutation of a new locus, galS, as it may occur after activation of caspase.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>the requirement of induction was eliminated by mutation of a new locus, galS at a concentration 10 times higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>the requirement of induction was eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>the requirement of induction will be eliminated by mutation of a new locus, galS at a concentration of 10-fold-higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>the same mutations has eliminated sec integration while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>the same mutations located within O2 or between OT and O1 eliminates sec integration, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>the same mutations removes sec integration eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>the same mutations that eliminated sec integration was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>the same mutations), sec integration can be completely eliminated (figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>the same mutations, as can occur after caspase activation, eliminated sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>the same mutations, as can occur after caspase activation, has eliminated sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>the same mutations, such as CD14, can eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>the stabilization observed with MG132 has been eliminated by staurosporin (or genestein; M-NEG data do not show), as may occur after activation of caspase.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>the stabilization observed with MG132 was eliminated by staurosporin (or genestein; M-NEG data do not show).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>these mutations eliminates secincorporation, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>these mutations that eliminated secincorporation was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>these mutations that eliminates secincorporation is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>these mutations, such as CD14, eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>these same mutations eliminated Sec incorporation while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>these same mutations located in O2 or between OT and O1 will eliminate Sec incorporation, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>these same mutations may eliminate sec incorporation while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>these same mutations removes Sec incorporation eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>these same mutations removes sec incorporation eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>these same mutations that eliminated Sec incorporation was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>vital stem cells is eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>vital stem cells was eliminated by inhibition of any of these molecules at a concentration 10 times higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>vital stem cells will be eliminated by inhibition of any of these molecules at a concentration of 10-fold-higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>As illustrated in Figure 1, exogeneous H(2)O(2) is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>As illustrated in Figure 1, inhibiating phosphorylation was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>As illustrated in Figure 1, inhibiating phosphorylation will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>As illustrated in Figure 1, inhibits phosphorylation was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>By eliminating the inhibiting phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>In a 3 bp deletion in frames , a sparring residue will be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>In a 3 bp deletion in frames, an asparaginal residue will be completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>In a 3 bp deletion in the graph , asparagine residues is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>In a 3-bp deletion in the chart, it is observed that asparagine residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>In a 3-bp deletion in the table, asparagine residue will be completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>In a 3bp deletion in frames, an asparagine residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>In a 3bp deletion in frames, it is observed that a sparring residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>In mutation of a new locus, gals , the requirement of induction is completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>In the gel-shift assay, a 3 bp deletion in frames eliminated an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>In the ice shift test, a 3 bp deletion in frames eliminates an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>In the ice-change test, a 3 bp deletion in frames will eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>In the ice-change test, a 3-bp deletion in the chart will eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>In the ice-change test, mutation of a new locus, gals will eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a 3 bp deletion in frames can completely eliminate a sparring residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a 3-bp deletion in the chart can completely eliminate asparagine residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a 3-bp deletion in the table can completely eliminate asparagine residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3-bp deletion in the table completely eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3bp deletion in frames completely eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3 bp deletion in frames completely removes an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3-bp deletion in the table completely removes asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3bp deletion in frames completely removes an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, the requirement of induction was completely eliminated by mutation of a new locus, gals.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3bp deletion in frames completely eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a 3 bp deletion in frames can completely eliminate a sparring residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a 3 bp deletion in frames can completely eliminate an asparaginal residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3 bp deletion in frames completely removes an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3bp deletion in frames completely removes an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>The same activation level of B-Raf occurs only when inhibiting phosphorylation has been eliminated.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>They claim that a 3-bp deletion in the table, as can occur after caspase activation, can eliminate asparagine residue necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>They claim that a 3bp deletion in frames, as can occur after caspase activation, can eliminate a sparring residue necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>This eliminating in a 3bp deletion in frames for the removal of a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>This occurs by a 3 bp deletion in the graph to eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>This occurs in a 3 bp deletion in frames to eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>This occurs in a 3 bp deletion in the graph to eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>This occurs in a 3-bp deletion in the chart to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>a 3 bp deletion in frames eliminated a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>a 3 bp deletion in frames eliminates a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>a 3 bp deletion in frames eliminates a sparring residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>a 3 bp deletion in frames has eliminated an asparaginal residue into a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>a 3 bp deletion in frames may eliminate an asparaginal residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>a 3 bp deletion in frames, as may occur after caspase activation, eliminates a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>a 3 bp deletion in the graph eliminated asparagine residues into product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>a 3 bp deletion in the graph located inside O2 or between OT and O1 eliminated asparagine residues, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>a 3 bp deletion in the graph, such as CD14, eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>a 3 bp deletion in the graph, such as CD14, eliminated asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>a 3-bp deletion in the chart can eliminate asparagine residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>a 3-bp deletion in the chart eliminates asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>a 3-bp deletion in the chart has eliminated asparagine residue into product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>a 3-bp deletion in the chart located in O2 or between OT and O1 will eliminate asparagine residue, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>a 3-bp deletion in the chart located inside O2 or between OT and O1 eliminated asparagine residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>a 3-bp deletion in the chart that eliminated asparagine residue was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>a 3-bp deletion in the chart would eliminate asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>a 3-bp deletion in the chart, as can occur after caspase activation, eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>a 3-bp deletion in the table eliminated asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>a 3-bp deletion in the table is able to eliminate asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>a 3-bp deletion in the table located inside O2 or between OT and O1 eliminated asparagine residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>a 3-bp deletion in the table removes asparagine residue eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>a 3bp deletion in frames eliminated an asparagine residue in a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>a 3bp deletion in frames has eliminated an asparagine residue into a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>a 3bp deletion in frames is able to eliminate an asparagine residue into a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>a 3bp deletion in frames located inside O2 or between OT and O1 eliminates an asparagine residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>a 3bp deletion in frames may eliminate an asparagine residue into a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>a 3bp deletion in frames would eliminate a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>a 3bp deletion in frames would eliminate an asparagine residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>a 3bp deletion in frames, as can occur after caspase activation, eliminated an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>a 3bp deletion in frames, as may occur after activation of caspase, is able to eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>a sparring residue has been eliminated by a 3bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>a sparring residue is eliminated by a 3bp deletion in frames to a product kinase domain, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>a sparring residue is eliminated by a 3bp deletion in frames, as it may occur after activation of caspase.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>a sparring residue is eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>a sparring residue is eliminated in a product kinase domain by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>a sparring residue is eliminated in a product kinase domain to a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>a sparring residue was eliminated by a 3 bp deletion in frames at a concentration 10 times higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>a sparring residue was eliminated in a product kinase domain by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>an asparaginal residue has been eliminated by a 3 bp deletion in frames, as may occur after activation of caspase.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>an asparaginal residue was eliminated in a product kinase domain by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>an asparaginal residue was eliminated in a product kinase domain for a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>an asparagine residue is eliminated by a 3bp deletion in frames to a product kinase domain, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames at a concentration 10 times higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the table at a concentration 10 times higher.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>asparagine residue was eliminated in product kinase domain by a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>asparagine residue was eliminated in product kinase domain for a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>asparagine residues has been eliminated by a 3 bp deletion in the graph, as may occur after activation of caspase.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>asparagine residues was eliminated by a 3 bp deletion in the graph, such as CD14.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>asparagine residues will be eliminated by a 3 bp deletion in the graph at a concentration 10 times higher.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>eliminate inhibitory phosphorylation causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>eliminating exogeneous H(2)O(2) causes the same B-Raf activation level to occur.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>eliminating inhibits phosphorylation causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>eliminating inhibits phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>inhibits phosphorylation eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>mutation of a new locus, gals located inside O2 or between OT and O1 eliminated the requirement of induction, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>mutation of a new locus, gals located within O2 or between OT and O1 eliminates the requirement of induction, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>mutation of a new locus, gals, as may occur after caspase activation, eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>mutation of a new locus, gals, such as CD14, eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>the requirement of induction will be eliminated by mutation of a new locus, gals at a concentration of 10-fold-higher.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
